David Scadden - 30 May 2024 Form 4 Insider Report for Editas Medicine, Inc. (EDIT)

Role
Director
Signature
/s/ David Scadden
Issuer symbol
EDIT
Transactions as of
30 May 2024
Net transactions value
$0
Form type
4
Filing time
03 Jun 2024, 17:15:27 UTC
Previous filing
23 Jun 2023
Next filing
17 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EDIT Stock Option (right to buy) Award $0 +25,000 $0.000000 25,000 30 May 2024 Common Stock 25,000 $5.17 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on May 30, 2024 and is scheduled to vest in full on May 30, 2025